CRIS Current Research Information System

PECCI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.111
NA - Nord America 365
EU - Europa 192
SA - Sud America 45
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.734
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 356
CN - Cina 315
SG - Singapore 303
VN - Vietnam 258
HK - Hong Kong 93
IT - Italia 61
KR - Corea 46
BR - Brasile 33
DE - Germania 30
IN - India 29
NL - Olanda 29
FI - Finlandia 21
JP - Giappone 14
FR - Francia 11
AR - Argentina 9
AT - Austria 8
ID - Indonesia 8
BE - Belgio 6
GB - Regno Unito 6
PH - Filippine 6
RU - Federazione Russa 6
TH - Thailandia 6
BD - Bangladesh 5
CI - Costa d'Avorio 5
IQ - Iraq 5
MX - Messico 5
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CA - Canada 3
IL - Israele 3
LT - Lituania 3
PL - Polonia 3
SC - Seychelles 3
TW - Taiwan 3
BG - Bulgaria 2
ES - Italia 2
KE - Kenya 2
NP - Nepal 2
SA - Arabia Saudita 2
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
GA - Gabon 1
GR - Grecia 1
IE - Irlanda 1
JO - Giordania 1
LY - Libia 1
MA - Marocco 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
SE - Svezia 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 1.734
Salva come PNG Salva come JPEG
Città #
Singapore 213
Hefei 114
Hong Kong 90
Ashburn 76
Ho Chi Minh City 66
Hanoi 65
San Jose 59
Santa Clara 46
Seoul 43
Boardman 22
Beijing 20
Helsinki 20
Bologna 17
Tokyo 13
Bengaluru 11
Council Bluffs 10
Da Nang 10
Haiphong 10
Falkenstein 9
Los Angeles 9
Nuremberg 9
Shanghai 9
Buffalo 8
Dallas 8
Frankfurt am Main 8
Hyderabad 8
Lauterbourg 8
Can Tho 7
Guangzhou 7
Jakarta 7
Redondo Beach 7
New York 6
Orem 6
Abidjan 5
Biên Hòa 5
Modena 5
São Paulo 5
The Dalles 5
Bình Phước 4
Ha Long 4
Hangzhou 4
Indianapolis 4
San Francisco 4
Tongling 4
Verona 4
Wuhan 4
Amsterdam 3
Brussels 3
Bắc Giang 3
Chengdu 3
Denver 3
Harbin 3
Mumbai 3
Munich 3
Pietrasanta 3
Quận Một 3
Quận Phú Nhuận 3
Salt Lake City 3
Tel Aviv 3
Tianjin 3
Turin 3
Vienna 3
Warsaw 3
Wuxi 3
Atlanta 2
Baghdad 2
Bonate Sopra 2
Brooklyn 2
Bắc Ninh 2
Foshan 2
Houston 2
Hải Dương 2
Medina 2
Mexico City 2
Milan 2
Montreal 2
Moscow 2
Nairobi 2
New Delhi 2
Ninh Bình 2
Pescara 2
Quảng Ngãi 2
Quận Bình Thạnh 2
Rome 2
Salerno 2
Seattle 2
Shenzhen 2
Sofia 2
Taurianova 2
Thái Bình 2
Thái Nguyên 2
Vinh 2
Vĩnh Tường 2
Xi'an 2
Yubileyny 2
Al Hillah 1
Algiers 1
Amparo 1
Angeles City 1
Aparecida 1
Totale 1.199
Salva come PNG Salva come JPEG
Nome #
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors 184
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors 147
Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406] 128
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC 126
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer 119
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer 107
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study 104
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer 99
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer 84
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma 80
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease 80
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer 78
The gustave roussy immune (Grim)-score variation is an early-on-treatment biomarker of outcome in advanced non-small cell lung cancer (nsclc) patients treated with first-line pembrolizumab 76
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer 76
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC 67
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions 61
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC 60
Non-small-cell lung cancer: how to manage EGFR-mutated disease 55
Title: Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer 52
Totale 1.783
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.288
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 0 0 0 0 2 2 0 2
2023/202434 0 1 1 2 1 2 2 13 2 4 1 5
2024/2025513 5 42 59 27 74 17 39 24 10 37 56 123
2025/20261.230 234 155 116 114 99 61 134 42 182 93 0 0
Totale 1.783